Literature DB >> 29025773

Erdheim-Chester disease: atypical presentation of a rare disease.

Cristian Ricardo Calandra1,2, Ariel Bustos1, Florencia Falcon3, Naomi Arakaki4.   

Abstract

We report the clinical case of an adult patient referred to our hospital because of trismus due to a tumour in the right infratemporal and pterygomaxillary fossa. He referred hyporexia, weight loss and right trigeminal neuralgia. On physical examination, he had trismus and diplopia. On neuroimaging, the tumour invaded the central nervous system affecting the right temporal lobe and orbit, and the sellar region. Tumour biopsy revealed foamy histiocytes and isolated giant multinuclear cells immunoreactive to CD68 and negative to CD1a and S100. A diagnosis of Erdheim-Chester disease was made. Non-evidence of large bone involvement was found in neither plain radiographs nor Technetium 99 m bone scintigraphy. BRAFV600E mutation analysis was negative. Because of raised intracranial pressure, a debulking surgery of the intracranial histiocytic process was performed. The patient improved his symptoms and remains clinically stable after 12 months of treatment with pegylated interferon-α-2a 180 µg/weekly. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  haematology (incl bloodtransfusion); neurology

Mesh:

Substances:

Year:  2017        PMID: 29025773      PMCID: PMC5652343          DOI: 10.1136/bcr-2017-220827

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  30 in total

1.  Erdheim-Chester disease presenting as periodontal disease: Experience of treatment with cladribine, interferon-a, local radiotherapy and anakinra.

Authors:  Lena Blomstrand; Andreas Thor; Hans Hagberg
Journal:  Acta Oncol       Date:  2015-04-23       Impact factor: 4.089

2.  Consensus guidelines for the diagnosis and clinical management of Erdheim-Chester disease.

Authors:  Eli L Diamond; Lorenzo Dagna; David M Hyman; Giulio Cavalli; Filip Janku; Juvianee Estrada-Veras; Marina Ferrarini; Omar Abdel-Wahab; Mark L Heaney; Paul J Scheel; Nancy K Feeley; Elisabetta Ferrero; Kenneth L McClain; Augusto Vaglio; Thomas Colby; Laurent Arnaud; Julien Haroche
Journal:  Blood       Date:  2014-05-21       Impact factor: 22.113

3.  Palliative treatment of Erdheim-Chester disease with radiotherapy: a Rare Cancer Network study.

Authors:  Robert C Miller; Salvador Villà; Serra Kamer; David Pasquier; Philip Poortmans; Oliver Micke; Timothy G Call
Journal:  Radiother Oncol       Date:  2006-09-07       Impact factor: 6.280

4.  Cerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findings.

Authors:  Aurélie Drier; Julien Haroche; Julien Savatovsky; Gaelle Godenèche; Didier Dormont; Jacques Chiras; Zahir Amoura; Fabrice Bonneville
Journal:  Radiology       Date:  2010-05       Impact factor: 11.105

5.  Combined Erdheim-Chester disease and Langerhans cell histiocytosis of skin are both monoclonal: a rare case with human androgen-receptor gene analysis.

Authors:  Jen-Wei Tsai; Jen-Hui Tsou; Liang-Yi Hung; Hung-Bo Wu; Kung-Chao Chang
Journal:  J Am Acad Dermatol       Date:  2010-08       Impact factor: 11.527

Review 6.  Erdheim-Chester disease: characteristics and management.

Authors:  Javier Munoz; Filip Janku; Philip R Cohen; Razelle Kurzrock
Journal:  Mayo Clin Proc       Date:  2014-05-09       Impact factor: 7.616

7.  Failure of radiation therapy for brain involvement in Erdheim Chester disease.

Authors:  Mario Mascalchi; Patrizia Nencini; Marco Nistri; Cristina Sarti; Riccardo Santoni
Journal:  J Neurooncol       Date:  2002-09       Impact factor: 4.130

8.  Erdheim-Chester disease mimicking a primary brain tumor. Case report.

Authors:  Elisabeth J Rushing; John Paul Bouffard; Chris J Neal; Kelly Koeller; Jonathan Martin; Metin Ozdemirli; Hernando Mena; James M Ecklund
Journal:  J Neurosurg       Date:  2004-06       Impact factor: 5.115

Review 9.  Radiotherapy for Erdheim-Chester disease.

Authors:  Katsunori Matsui; Yasushi Nagata; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

Review 10.  Bone Involvement in Rosai-Dorfman Disease (RDD): a Case Report and Systematic Literature Review.

Authors:  Birgit A Mosheimer; Bastian Oppl; Shahin Zandieh; Michael Fillitz; Felix Keil; Klaus Klaushofer; Günter Weiss; Jochen Zwerina
Journal:  Curr Rheumatol Rep       Date:  2017-05       Impact factor: 4.592

View more
  2 in total

1.  Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient series.

Authors:  Ankush Bhatia; Vaios Hatzoglou; Gary Ulaner; Raajit Rampal; David M Hyman; Omar Abdel-Wahab; Benjamin H Durham; Ahmet Dogan; Neval Ozkaya; Mariko Yabe; Kseniya Petrova-Drus; Katherine S Panageas; Anne Reiner; Marc Rosenblum; Eli L Diamond
Journal:  Neuro Oncol       Date:  2020-07-07       Impact factor: 12.300

Review 2.  Erdheim-Chester Disease with Isolated CNS Involvement: A Systematic Review of the Literature.

Authors:  Anam Haque; Carlos A Pérez; Thejasvi A Reddy; Rajesh K Gupta
Journal:  Neurol Int       Date:  2022-09-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.